Thill M, Wimberger P, Grafe A, Klare P, et al. Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958). Breast Cancer Res Treat 2022 Sep 12. pii: 10.1007/s10549-022-06710.
PMID: 36094611